Brazil Blocks Health Insurer Hapvida From Repricing 947,000 Plans
Brazil · Business
Key Facts
- —The order ANS president Wadih Damous signed a precautionary measure, reported on August 20, 2026, freezing price rises and cancellations at Hapvida.
- —The scope About 947,000 members were flagged for review, roughly 11% of the insurer’s 8.67 million health plan users in June 2026.
- —The market HAPV3 shares fell about 5% on August 20, after closing the previous day at R$6.56 (about US$1.27).
- —The company Hapvida says it was not formally notified, and that the plan targets unpaid bills and loss-making corporate contracts.
- —The rulebook ANS caps individual plan increases at 5.11% for May 2026 to April 2027, while collective plans have no cap at all.
The company says nobody has formally served it with the order, and it has asked the regulator for a hearing.

Brazil’s health regulator has ordered Hapvida to stop repricing or cancelling almost a million health plans. The agency’s president signed a precautionary order, reported on Thursday, August 20, and summoned the company to explain itself.
Shares in the insurer fell about 5% on the day.
What Brazil’s Regulator Actually Did
Brazil’s private health watchdog is called ANS, short for Agência Nacional de Saúde Suplementar. Its president, Wadih Damous, signed what Brazilian law calls a medida cautelar, a precautionary order.
Because of it, the insurer cannot apply double-digit price rises or terminate the contracts under review. It holds until the company answers the agency’s questions.
This is not a fine, and it is not a final ruling. Instead, it is a freeze button pressed while the regulator investigates the case.
Why Hapvida Flagged 947,000 Members
The number came from Hapvida itself. In fact, its second-quarter report, published on August 12, said roughly 947,000 lives met new commercial review criteria.
That is about 11% of its health plan base. Moreover, the company said those members were either behind on payments or priced below what their care costs.
Because the plan was disclosed to investors, it reached newspapers within a day. After that, the regulator started asking questions.
Live Company IntelligenceHapvida Participações e Investimentos S.A. — the full investor dossier
Valuation & profitability
Price & risk
$6.1452-wk high
$42.66
Revenue trend · 6y
Ownership
Dividend
Contracts or People? The Count Is Murky
Coverage has used two different units for the same 947,000 figure. For example, Valor Econômico described them as lives, while O Globo described them as contracts.
O Globo added that the contracts are mostly collective plans, equal to about 12% of that part of the book. Meanwhile, Damous said the agency still wants the company to state how many consumers sit behind those contracts.
In short, the headline number is firm, yet what it counts is not. That gap is one reason the regulator asked for documents.
The Risk Selection Question
Damous framed the issue bluntly. In fact, he said the move had “a very strong appearance of risk selection, which is prohibited and which ANS will investigate.
Risk selection means shedding the customers who cost the most and keeping the cheap ones. Brazilian rules forbid it, because insurance only works when healthy and sick members share a pool.
So far the agency has not proved that happened here. Still, the size of the group was enough to trigger a formal look.
Hapvida’s Side of the Story
The company pushed back the same day. In a note to Valor, Hapvida said it had not been notified, so it had requested a hearing with the regulator.
It said it was never “called to provide clarification or present the technical, contractual and regulatory elements related to the matter. ” However, that is a procedural complaint, not a denial that a review exists.
On substance, the insurer said the measures involve unpaid bills and the renegotiation of large corporate group contracts that lose money. Moreover, it said it acts in full respect of the law and the regulator.
How Brazil Prices Health Plans
Brazil splits private cover into two very different worlds. For instance, individual and family plans get an annual increase ceiling set by ANS.
For anniversaries between May 2026 and April 2027, that ceiling is 5.11%. By contrast, the previous year’s cap was 6.06%.
Collective plans work differently. Since the agency sets no ceiling for them, the insurer and the contracting company negotiate the number directly.
When an Insurer Can Cancel a Contract
Cancellation rules split along the same line. For example, an individual plan ends only for proven fraud or for non-payment beyond sixty days.
By contrast, collective contracts are far easier to end. The operator may terminate them unilaterally, once the company or association is warned.
Even then, patients already in hospital must be covered until discharge. So the freedom is real, although it is not unlimited.
What the Share Price Says
The market was already jumpy. For instance, on August 13 the stock crashed 33.09% to R$6.41 (about US$1.24), its worst session since November 2025.
By August 19 it had edged back to R$6.56, roughly US$1.27. Then the regulator’s order landed, and the shares gave up about 5% again.
Over twelve months the company has shed some R$14.2 billion in market value, close to US$2.7 billion. In short, that is a fall of about 82%.
The Numbers Behind the Squeeze
The second quarter explains the pressure. For example, adjusted net profit came in at R$12.5 million, near US$2.4 million, down 95.8% in a year.
On a reported basis the company booked a loss of R$217.1 million, about US$41.9 million. Its cash loss ratio, the share of premiums eaten by medical costs, rose to 75.2%.
In addition, legal deposits tied to patient lawsuits reached R$1.2 billion, roughly US$232 million. Membership slipped by 16,000 in the quarter to 8.67 million.
Why the Regulator Is Leaning In
This is not a one-off mood. Damous has argued since taking office in September 2025 that unilateral cancellations often look like risk selection.
Moreover, he has floated stricter rules for group plan increases and tighter protection for older members. Those ideas sit in the agency’s 2026 to 2029 regulatory agenda.
Brazil’s private system covered 53.1 million people in medical plans in June 2026. Therefore any rule change here moves a very large market.
That is why the sector watches the agency closely.
What Happens Next
The company must hand over documents and meet agency officials. Still, no public deadline or meeting date has been announced.
The freeze stays in place while that happens. If the regulator is satisfied, the plan can resume; if not, sanctions become possible.
Neither side has published the full text of the order. Therefore the precise legal scope still rests on press accounts and the two parties’ statements.
What It Means for Foreigners in Brazil
Most foreign residents buy either an individual plan or a company plan. However, only individual plans carry the ANS ceiling and strong cancellation protection.
Company and association plans are cheaper up front, yet they can be repriced freely and ended with notice. That trade-off is exactly what this dispute exposes.
Before signing a Brazilian plan, ask which category it falls into. Overall, the answer decides how much price certainty you actually own.
Frequently Asked Questions
Did ANS cancel anyone’s health plan?
No. The order does the opposite: it stops Hapvida from cancelling or repricing the contracts under review while the agency investigates.
Is the order permanent?
No. It is a precautionary measure, meant to hold the situation still until the company provides explanations and documents.
Does Hapvida accept the order?
The company says it had not been formally notified and has asked for a hearing. It also says the plan targets unpaid bills and loss-making corporate contracts.
Why can collective plans be repriced so sharply?
Because ANS sets no ceiling for them. Only individual and family plans get an annual cap, which is 5.11% for May 2026 to April 2027.
Connected Coverage
Sources: Valor Econômico; O Globo; Folha de S.Paulo; InfoMoney; ANS.
This article was drafted with automated assistance and reviewed before publication. How we use AI · Report an error
Read More from The Rio Times
- Brazil’s Meal Voucher Market Is Worth 150 Billion Reais a Year, and Two More Banks Just Walked In
- Casas Bahia Has Filed for Court Protection Owing 17 Billion Reais. Banco do Brasil Is In for 2.9 Billion of It
- Vale Says Fixing Brazil’s Permit System Is Worth 1.3 Trillion Reais. It Also Wants a Mineral Washington Is Chasing